{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T17:55:29Z","timestamp":1726163729705},"reference-count":26,"publisher":"Royal College of Psychiatrists","issue":"2","license":[{"start":{"date-parts":[[2018,1,29]],"date-time":"2018-01-29T00:00:00Z","timestamp":1517184000000},"content-version":"unspecified","delay-in-days":11685,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Psychiatry"],"published-print":{"date-parts":[[1986,2]]},"abstract":"<jats:p>The radioreceptor assay for the measurement of neuroleptic drugs in serum has been used to study the relationship between dose and serum level in schizophrenic patients receiving these drugs. The assay was found to be reproducible and capable of detecting neuroleptics in the sera of patients receiving a range of both oral and depot drugs, with the exception of trifluoperazine spansules. Linear correlations were obtained between daily dose and serum level for each drug both in individual patients on different doses and between patients on a stable dose. Extrapyramidal side effects were related to the serum neuroleptic level within, but not between, patients. The assay may be of use in clinical practice, including the assessment of compliance or poor response to neuroleptics.<\/jats:p>","DOI":"10.1192\/bjp.148.2.187","type":"journal-article","created":{"date-parts":[[2008,8,12]],"date-time":"2008-08-12T23:43:23Z","timestamp":1218584603000},"page":"187-193","source":"Crossref","is-referenced-by-count":25,"title":["Radio Receptor Assay of Serum Neuroleptic Levels in Psychiatric Patients"],"prefix":"10.1192","volume":"148","author":[{"given":"Janet","family":"Krska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Sampath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. D.","family":"Soni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"170","published-online":{"date-parts":[[2018,1,29]]},"reference":[{"key":"S0007125000209744_ref19","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1972136931"},{"key":"S0007125000209744_ref4","doi-asserted-by":"publisher","DOI":"10.1007\/BF00435313"},{"key":"S0007125000209744_ref16","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1973146978"},{"key":"S0007125000209744_ref2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1982.04290090008002"},{"key":"S0007125000209744_ref24","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1176\/ajp.139.8.1054","article-title":"Red blood cell and plasma levels of haloperidol and clinical response in schizophrenia","volume":"139","author":"Smith","year":"1982","journal-title":"American Journal of Psychiatry"},{"key":"S0007125000209744_ref21","doi-asserted-by":"publisher","DOI":"10.1038\/261717a0"},{"key":"S0007125000209744_ref9","first-page":"1123","article-title":"Fluphenazine blood levels and clinical response","volume":"17","author":"Harris","year":"1982","journal-title":"Biological Psychiatry"},{"key":"S0007125000209744_ref23","first-page":"451","article-title":"Receptor techniques in the study of plasma levels of neuroleptics and antidepressant drugs","volume":"4","author":"Smith","year":"1980","journal-title":"Communications in Psychopharmacology"},{"key":"S0007125000209744_ref25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1176\/ajp.137.2.187","article-title":"Clinical stete and serum neuroleptic levels measured by radioreceptor assay in schizophrenia","volume":"137","author":"Tune","year":"1980","journal-title":"American Journal of Psychiatry"},{"key":"S0007125000209744_ref26","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700015841"},{"key":"S0007125000209744_ref5","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(80)90041-6"},{"key":"S0007125000209744_ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1970.tb02066.x"},{"key":"S0007125000209744_ref3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0165-1781(79)90026-X","article-title":"Serum levels of neuroleptics measured by dopamine radio-receptor assay and some clinical observations","volume":"1","author":"Caul","year":"1979","journal-title":"Psychiatry Research"},{"key":"S0007125000209744_ref6","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(80)90074-8"},{"key":"S0007125000209744_ref7","doi-asserted-by":"publisher","DOI":"10.1038\/270180a0"},{"key":"S0007125000209744_ref8","first-page":"929","article-title":"The relationship between plasma and red blood cell neuroleptic levels, oral dosage and clinical parameters in a chronic schizophrenic population","volume":"17","author":"Dunlop","year":"1982","journal-title":"Biological Psychiatry"},{"key":"S0007125000209744_ref10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00427479","article-title":"Clinical significance of plasma chlorpromazine levels","volume":"49","author":"Kolakowska","year":"1976","journal-title":"Psychopharmacology"},{"key":"S0007125000209744_ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1974.tb00281.x"},{"key":"S0007125000209744_ref13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1176\/ajp.138.3.365","article-title":"Relationship of serum haloperidol levels to clinical response in schizophrenic patients","volume":"138","author":"Magliozzi","year":"1981","journal-title":"American Journal of Psychiatry"},{"key":"S0007125000209744_ref14","doi-asserted-by":"publisher","DOI":"10.2466\/pr0.1962.10.3.799"},{"key":"S0007125000209744_ref15","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.137.6.518"},{"key":"S0007125000209744_ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1981.tb01135.x"},{"key":"S0007125000209744_ref20","doi-asserted-by":"publisher","DOI":"10.1007\/BF00422150"},{"key":"S0007125000209744_ref11","doi-asserted-by":"publisher","DOI":"10.1080\/01971528008055776"},{"key":"S0007125000209744_ref1","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1176\/ajp.137.6.653","article-title":"The clinical application of tricyclic antidepressant pharmacokinetics and plasma levels","volume":"137","author":"Amsterdam","year":"1980","journal-title":"American Journal of Psychiatry"},{"key":"S0007125000209744_ref17","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1176\/ajp.133.6.646","article-title":"Clinical response and plasma levels: effect of dose, dosage schedules and drug interactions on plasma chlorpromazine levels","volume":"133","author":"Rivera-Calimim","year":"1976","journal-title":"American Journal of Psychiatry"}],"container-title":["British Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0007125000209744","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T15:06:43Z","timestamp":1684508803000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0007125000209744\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1986,2]]}},"alternative-id":["S0007125000209744"],"URL":"https:\/\/doi.org\/10.1192\/bjp.148.2.187","relation":{},"ISSN":["0007-1250","1472-1465"],"issn-type":[{"value":"0007-1250","type":"print"},{"value":"1472-1465","type":"electronic"}],"subject":[],"published":{"date-parts":[[1986,2]]}}}